Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity

case studies

Damoiseaux JS, Greicius MD.
GSID: 6ojzf5PWwZEJ
JS Damoiseaux, MD Greicius - Brain structure and function, 2009 - Springer

… We discuss eight articles that directly compare resting-state functional connectivity with structural connectivity and three clinical case studies of patients with limited white matter connections between the cerebral hemispheres. All studies examined show largely convergent …

Cite
Damoiseaux, J. S., & Greicius, M. D. (2009). Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity. Brain structure and function, 213(6), 525-533.
Damoiseaux, Jessica S., and Michael D. Greicius. "Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity." Brain structure and function 213.6 (2009): 525-533.
Copy Download .nbib Format: MLA
[Diversity and quality in medical training].

Nederlands tijdschrift voor geneeskunde

Damoiseaux RA, Blankenstein AH, Vermeulen MI.
PMID: 27650027
Ned Tijdschr Geneeskd. 2016;160:D670.

Ethnocultural diversity among medical students is important in order to guarantee a true reflection of society in the medical profession. It is known that students from ethnic minority groups perform less well in assessments during medical training. This is...

Cite
Damoiseaux RA, Blankenstein AH, Vermeulen MI. Diversiteit en kwaliteit in de geneeskundestudie. [Diversity and quality in medical training]. Ned Tijdschr Geneeskd. 2016;160:D670
Damoiseaux, R. A., Blankenstein, A. H., & Vermeulen, M. I. (2016). Diversiteit en kwaliteit in de geneeskundestudie. [Diversity and quality in medical training]. Nederlands tijdschrift voor geneeskunde, 160D670.
Damoiseaux, R A M J, et al. "Diversiteit en kwaliteit in de geneeskundestudie." [Diversity and quality in medical training]. Nederlands tijdschrift voor geneeskunde vol. 160 (2016): D670.
Damoiseaux RA, Blankenstein AH, Vermeulen MI. Diversiteit en kwaliteit in de geneeskundestudie. [Diversity and quality in medical training]. Ned Tijdschr Geneeskd. 2016;160:D670. Dutch. PMID: 27650027.
Copy Download .nbib Format: NLM
Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men.

Brain imaging and behavior

Oei NY, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JP, Veltman DJ, Scheltens P, Rombouts SA.
PMID: 19946603
Brain Imaging Behav. 2007 Jun;1(1):31-41. doi: 10.1007/s11682-007-9003-2. Epub 2007 Jun 01.

Glucocorticoids (GCs, cortisol in human) are associated with impairments in declarative memory retrieval. Brain regions hypothesized to mediate these effects are the hippocampus and prefrontal cortex (PFC). Our aim was to use fMRI in localizing the effects of GCs...

Cite
Oei NY, Elzinga BM, Wolf OT, et al. Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men. Brain Imaging Behav. 2007;1(1):31-41doi: 10.1007/s11682-007-9003-2.
Oei, N. Y., Elzinga, B. M., Wolf, O. T., de Ruiter, M. B., Damoiseaux, J. S., Kuijer, J. P., Veltman, D. J., Scheltens, P., & Rombouts, S. A. (2007). Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men. Brain imaging and behavior, 1(1), 31-41. https://doi.org/10.1007/s11682-007-9003-2
Oei, Nicole Y L, et al. "Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men." Brain imaging and behavior vol. 1,1 (2007): 31-41. doi: https://doi.org/10.1007/s11682-007-9003-2
Oei NY, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JP, Veltman DJ, Scheltens P, Rombouts SA. Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men. Brain Imaging Behav. 2007 Jun;1(1):31-41. doi: 10.1007/s11682-007-9003-2. Epub 2007 Jun 01. PMID: 19946603; PMCID: PMC2780685.
Copy Download .nbib Format: NLM
Resting-state fMRI as a biomarker for Alzheimer's disease?.

Alzheimer's research & therapy

Damoiseaux JS.
PMID: 22423634
Alzheimers Res Ther. 2012 Mar 15;4(2):8. doi: 10.1186/alzrt106.

Previous work indicates that resting-state functional magnetic resonance imaging (fMRI) is sensitive to functional brain changes related to Alzheimer's disease (AD) pathology across the clinical spectrum. Cross-sectional studies have found functional connectivity differences in the brain's default mode network...

Cite
Damoiseaux JS. Resting-state fMRI as a biomarker for Alzheimer's disease?. Alzheimers Res Ther. 2012;4(2):8doi: 10.1186/alzrt106.
Damoiseaux, J. S. (2012). Resting-state fMRI as a biomarker for Alzheimer's disease?. Alzheimer's research & therapy, 4(2), 8. https://doi.org/10.1186/alzrt106
Damoiseaux, Jessica S. "Resting-state fMRI as a biomarker for Alzheimer's disease?." Alzheimer's research & therapy vol. 4,2 (2012): 8. doi: https://doi.org/10.1186/alzrt106
Damoiseaux JS. Resting-state fMRI as a biomarker for Alzheimer's disease?. Alzheimers Res Ther. 2012 Mar 15;4(2):8. doi: 10.1186/alzrt106. PMID: 22423634; PMCID: PMC3334541.
Copy Download .nbib Format: NLM
Gastrointestinal-associated autoantibodies in different autoimmune diseases.

American journal of clinical and experimental immunology

Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y.
PMID: 23885314
Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012.

BACKGROUND: Gastrointestinal (GI)-related autoantibodies (Abs) are rarely evaluated in autoimmune diseases (AID) other than inflammatory bowel disease, autoimmune hepatitis and celiac disease. Our aim was to determine the prevalence of these antibodies in a wide spectrum of AID.METHODS: We...

Cite
Shor DB, Orbach H, Boaz M, et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012;1(1):49-55
Shor, D. B., Orbach, H., Boaz, M., Altman, A., Anaya, J. M., Bizzaro, N., Tincani, A., Cervera, R., Espinosa, G., Stojanovich, L., Rozman, B., Bombardieri, S., Vita, S. D., Damoiseaux, J., Villalta, D., Tonutti, E., Tozzoli, R., Barzilai, O., Ram, M., Blank, M., Agmon-Levin, N., & Shoenfeld, Y. (2012). Gastrointestinal-associated autoantibodies in different autoimmune diseases. American journal of clinical and experimental immunology, 1(1), 49-55.
Shor, Dana Ben-Ami, et al. "Gastrointestinal-associated autoantibodies in different autoimmune diseases." American journal of clinical and experimental immunology vol. 1,1 (2012): 49-55.
Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012. PMID: 23885314; PMCID: PMC3714189.
Copy Download .nbib Format: NLM
International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results.

Auto- immunity highlights

Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K.
PMID: 26831867
Auto Immun Highlights. 2016 Dec;7(1):1. doi: 10.1007/s13317-016-0075-0. Epub 2016 Jan 30.

The International Consensus on ANA Patterns (ICAP) was initiated as a workshop aiming to thoroughly discuss and achieve consensus regarding the morphological patterns observed in the indirect immunofluorescence assay on HEp-2 cells. One of the topics discussed at the...

Cite
Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016;7(1):1doi: 10.1007/s13317-016-0075-0.
Damoiseaux, J., von Mühlen, C. A., Garcia-De La Torre, I., Carballo, O. G., de Melo Cruvinel, W., Francescantonio, P. L., Fritzler, M. J., Herold, M., Mimori, T., Satoh, M., Andrade, L. E., Chan, E. K., & Conrad, K. (2016). International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto- immunity highlights, 7(1), 1. https://doi.org/10.1007/s13317-016-0075-0
Damoiseaux, Jan, et al. "International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results." Auto- immunity highlights vol. 7,1 (2016): 1. doi: https://doi.org/10.1007/s13317-016-0075-0
Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016 Dec;7(1):1. doi: 10.1007/s13317-016-0075-0. Epub 2016 Jan 30. PMID: 26831867; PMCID: PMC4733811.
Copy Download .nbib Format: NLM
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.

Cancer & metabolism

Xu S, Catapang A, Braas D, Stiles L, Doh HM, Lee JT, Graeber TG, Damoiseaux R, Shirihai O, Herschman HR.
PMID: 29988332
Cancer Metab. 2018 Jun 28;6:7. doi: 10.1186/s40170-018-0181-8. eCollection 2018.

BACKGROUND: Precision medicine therapies require identification of unique molecular cancer characteristics. Hexokinase (HK) activity has been proposed as a therapeutic target; however, different hexokinase isoforms have not been well characterized as alternative targets. While HK2 is highly expressed in...

Cite
Xu S, Catapang A, Braas D, et al. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers. Cancer Metab. 2018;6:7doi: 10.1186/s40170-018-0181-8.
Xu, S., Catapang, A., Braas, D., Stiles, L., Doh, H. M., Lee, J. T., Graeber, T. G., Damoiseaux, R., Shirihai, O., & Herschman, H. R. (2018). A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers. Cancer & metabolism, 67. https://doi.org/10.1186/s40170-018-0181-8
Xu, Shili, et al. "A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers." Cancer & metabolism vol. 6 (2018): 7. doi: https://doi.org/10.1186/s40170-018-0181-8
Xu S, Catapang A, Braas D, Stiles L, Doh HM, Lee JT, Graeber TG, Damoiseaux R, Shirihai O, Herschman HR. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers. Cancer Metab. 2018 Jun 28;6:7. doi: 10.1186/s40170-018-0181-8. eCollection 2018. PMID: 29988332; PMCID: PMC6022704.
Copy Download .nbib Format: NLM
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis.

American journal of respiratory and critical care medicine

Moiseev S, Bossuyt X, Arimura Y, Blockmans D, Csernok E, Damoiseaux J, Emmi G, Flores-Suárez LF, Hellmich B, Jayne D, Jennette JC, Little MA, Mohammad AJ, Moosig F, Novikov P, Pagnoux C, Radice A, Sada KE, Segelmark M, Shoenfeld Y, Sinico RA, Specks U, Terrier B, Tzioufas AG, Vaglio A, Zhao MH, Cohen Tervaert JW.
PMID: 32584187
Am J Respir Crit Care Med. 2020 Jun 25; doi: 10.1164/rccm.202005-1628SO. Epub 2020 Jun 25.

An international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in eosinophilic granulomatosis with polyangiitis (EGPA) is presented. ANCA, specific for myeloperoxidase (MPO), can be detected in 30-35% of EGPA patients. MPO-ANCA should be tested with antigen-specific immunoassays in any...

Cite
Moiseev S, Bossuyt X, Arimura Y, et al. International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. Am J Respir Crit Care Med. 2020;doi: 10.1164/rccm.202005-1628SO.
Moiseev, S., Bossuyt, X., Arimura, Y., Blockmans, D., Csernok, E., Damoiseaux, J., Emmi, G., Flores-Suárez, L. F., Hellmich, B., Jayne, D., Jennette, J. C., Little, M. A., Mohammad, A. J., Moosig, F., Novikov, P., Pagnoux, C., Radice, A., Sada, K. E., Segelmark, M., Shoenfeld, Y., Sinico, R. A., Specks, U., Terrier, B., Tzioufas, A. G., Vaglio, A., Zhao, M. H., Cohen Tervaert, J. W. (2020). International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. American journal of respiratory and critical care medicine, . https://doi.org/10.1164/rccm.202005-1628SO
Moiseev, Sergey, et al. "International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis." American journal of respiratory and critical care medicine vol. (2020). doi: https://doi.org/10.1164/rccm.202005-1628SO
Moiseev S, Bossuyt X, Arimura Y, Blockmans D, Csernok E, Damoiseaux J, Emmi G, Flores-Suárez LF, Hellmich B, Jayne D, Jennette JC, Little MA, Mohammad AJ, Moosig F, Novikov P, Pagnoux C, Radice A, Sada KE, Segelmark M, Shoenfeld Y, Sinico RA, Specks U, Terrier B, Tzioufas AG, Vaglio A, Zhao MH, Cohen Tervaert JW. International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. Am J Respir Crit Care Med. 2020 Jun 25; doi: 10.1164/rccm.202005-1628SO. Epub 2020 Jun 25. PMID: 32584187.
Copy Download .nbib Format: NLM
The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice.

The journal of applied laboratory medicine

van Beers JJBC, Koek GH, Damoiseaux JGMC.
PMID: 34996079
J Appl Lab Med. 2022 Jan 05;7(1):259-267. doi: 10.1093/jalm/jfab099.

BACKGROUND: Primary biliary cholangitis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are autoimmune liver diseases associated with distinct autoantibodies. Diagnosis is based upon clinical, serological, and histopathology findings. The role of autoantibodies in the diagnosis of these...

Cite
van Beers JJBC, Koek GH, Damoiseaux JGMC. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. J Appl Lab Med. 2022;7(1):259-267doi: 10.1093/jalm/jfab099.
van Beers, J. J. B. C., Koek, G. H., & Damoiseaux, J. G. M. C. (2022). The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. The journal of applied laboratory medicine, 7(1), 259-267. https://doi.org/10.1093/jalm/jfab099
van Beers, Joyce J B C, et al. "The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice." The journal of applied laboratory medicine vol. 7,1 (2022): 259-267. doi: https://doi.org/10.1093/jalm/jfab099
van Beers JJBC, Koek GH, Damoiseaux JGMC. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. J Appl Lab Med. 2022 Jan 05;7(1):259-267. doi: 10.1093/jalm/jfab099. PMID: 34996079.
Copy Download .nbib Format: NLM
Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus.

Journal of translational autoimmunity

Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J.
PMID: 35028552
J Transl Autoimmun. 2021 Dec 28;5:100139. doi: 10.1016/j.jtauto.2021.100139. eCollection 2022.

Anti-double stranded DNA (dsDNA) antibodies play an important role in the diagnosis, classification and management of systemic lupus erythematosus (SLE), an autoimmune disease characterized by heterogeneous clinical manifestations and a wide range of autoantibodies, which makes the diagnosis quite...

Cite
Infantino M, Nagy E, Bizzaro N, et al. Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun. 2021;5:100139doi: 10.1016/j.jtauto.2021.100139.
Infantino, M., Nagy, E., Bizzaro, N., Fischer, K., Bossuyt, X., & Damoiseaux, J. (2022). Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus. Journal of translational autoimmunity, 5100139. https://doi.org/10.1016/j.jtauto.2021.100139
Infantino, Maria, et al. "Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus." Journal of translational autoimmunity vol. 5 (2022): 100139. doi: https://doi.org/10.1016/j.jtauto.2021.100139
Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J. Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun. 2021 Dec 28;5:100139. doi: 10.1016/j.jtauto.2021.100139. eCollection 2022. PMID: 35028552; PMCID: PMC8741517.
Copy Download .nbib Format: NLM
Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application.

Journal of translational autoimmunity

Damoiseaux J, Potjewijd J, Smeets RL, Bonroy C.
PMID: 35028553
J Transl Autoimmun. 2022 Jan 04;5:100141. doi: 10.1016/j.jtauto.2022.100141. eCollection 2022.

The ACR/EULAR classification criteria for systemic sclerosis (SSc) entail three autoantibodies: anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (ATA), and anti-RNA-polymerase III antibodies (ARA). The importance of ACA and ATA in the classification criteria is evidence based, but the diagnostic...

Cite
Damoiseaux J, Potjewijd J, Smeets RL, et al. Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application. J Transl Autoimmun. 2022;5:100141doi: 10.1016/j.jtauto.2022.100141.
Damoiseaux, J., Potjewijd, J., Smeets, R. L., & Bonroy, C. (2022). Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application. Journal of translational autoimmunity, 5100141. https://doi.org/10.1016/j.jtauto.2022.100141
Damoiseaux, Jan, et al. "Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application." Journal of translational autoimmunity vol. 5 (2022): 100141. doi: https://doi.org/10.1016/j.jtauto.2022.100141
Damoiseaux J, Potjewijd J, Smeets RL, Bonroy C. Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application. J Transl Autoimmun. 2022 Jan 04;5:100141. doi: 10.1016/j.jtauto.2022.100141. eCollection 2022. PMID: 35028553; PMCID: PMC8741499.
Copy Download .nbib Format: NLM
Isoquinoline thiosemicarbazone displays potent anticancer activity with .

RSC medicinal chemistry

Sun DL, Poddar S, Pan RD, Rosser EW, Abt ER, Van Valkenburgh J, Le TM, Lok V, Hernandez SP, Song J, Li J, Turlik A, Chen X, Cheng CA, Chen W, Mona CE, Stuparu AD, Vergnes L, Reue K, Damoiseaux R, Zink JI, Czernin J, Donahue TR, Houk KN, Jung ME, Radu CG.
PMID: 33479645
RSC Med Chem. 2020 Feb 24;11(3):392-410. doi: 10.1039/c9md00594c. eCollection 2020 Mar 01.

A potent class of isoquinoline-based α-N-heterocyclic carboxaldehyde thiosemicarbazone (HCT) compounds has been rediscovered; based upon this scaffold, three series of antiproliferative agents were synthesized through iterative rounds of methylation and fluorination modifications, with anticancer activities being potentiated by physiologically...

Cite
Sun DL, Poddar S, Pan RD, et al. Isoquinoline thiosemicarbazone displays potent anticancer activity with . RSC Med Chem. 2020;11(3):392-410doi: 10.1039/c9md00594c.
Sun, D. L., Poddar, S., Pan, R. D., Rosser, E. W., Abt, E. R., Van Valkenburgh, J., Le, T. M., Lok, V., Hernandez, S. P., Song, J., Li, J., Turlik, A., Chen, X., Cheng, C. A., Chen, W., Mona, C. E., Stuparu, A. D., Vergnes, L., Reue, K., Damoiseaux, R., Zink, J. I., Czernin, J., Donahue, T. R., Houk, K. N., Jung, M. E., & Radu, C. G. (2020). Isoquinoline thiosemicarbazone displays potent anticancer activity with . RSC medicinal chemistry, 11(3), 392-410. https://doi.org/10.1039/c9md00594c
Sun, Daniel L, et al. "Isoquinoline thiosemicarbazone displays potent anticancer activity with ." RSC medicinal chemistry vol. 11,3 (2020): 392-410. doi: https://doi.org/10.1039/c9md00594c
Sun DL, Poddar S, Pan RD, Rosser EW, Abt ER, Van Valkenburgh J, Le TM, Lok V, Hernandez SP, Song J, Li J, Turlik A, Chen X, Cheng CA, Chen W, Mona CE, Stuparu AD, Vergnes L, Reue K, Damoiseaux R, Zink JI, Czernin J, Donahue TR, Houk KN, Jung ME, Radu CG. Isoquinoline thiosemicarbazone displays potent anticancer activity with . RSC Med Chem. 2020 Feb 24;11(3):392-410. doi: 10.1039/c9md00594c. eCollection 2020 Mar 01. PMID: 33479645; PMCID: PMC7593890.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries